Navigation Links
PAL-MED CONNECT partners with Briefings in Palliative, Hospice, and Pain Medicine & Management
Date:10/4/2010

New Rochelle, NY, October 4, 2010 Briefings in Palliative, Hospice, and Pain Medicine & Management, the e-newsletter companion to Journal of Palliative Medicine published by Mary Ann Liebert, Inc. (www.liebertpub.com), is pleased to announce a collaboration with The Institute for Palliative Medicine's (www.palliativemed.org) PAL-MED CONNECT (http://palmedconnect.org/) hotline to create a new monthly feature for the e-newsletter. Each month, Briefings will now include a valuable case study focusing on patients with advanced pain and symptom management challenges, or chronic or life-threatening illness.

Briefings will present practical, clinical case studies encountered by callers to PAL-MED CONNECT. Anticipated subjects include pain management, safety and efficacy of opioids, opioid conversion, neuropathic pain symptoms, difficult family conversations, decision-making about NG tubes, and other key topics. The studies will initially appear on the last Wednesday of each month with the potential for them to appear more frequently based on reader response. The first case study (http://www.liebertpub.com/palliative/archive/2010/Sept_10/Sept_29_10.htm) was published on September 29, 2010.

The PAL-MED CONNECT hotline is a grant-funded hotline that provides free access for healthcare professionals seeking expertise and educational resources related to palliative care and complex symptom management. The hotline can be accessed by physicians, physician assistants, nurse practioners, pharmacists, nurses, and other healthcare professionals. Callers speak directly clinician to expert clinician, at no charge. The hotline is available at 1-877-PAL-MED4.

"This California based hotline is gaining attention from healthcare professionals nationwide. Healthcare professionals utilize the hotline when complex symptoms arise. We provide them with information on options for care and evidence based resources," states Charles von Gunten, MD, PhD, Provost of The Institute for Palliative Medicine.


'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2156
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Related biology news :

1. Connection between light at night and cancer revealed in additional study
2. Connection between light at night (LAN) and cancer revealed in additional study
3. Cactus genes connect modern Mexico to its prehistoric past
4. Researchers connect APC protein to autism and mental retardation
5. Brain connections break down as we age
6. Greenhouse gas calculator connects farming practices with carbon credits
7. Calcium connections: Basic pathway for maintaining cells fuel stores
8. Searching for causes of neural disconnection in schizophrenia
9. Connecting the dots: How light receptors get their message across
10. Connection elucidated between obesity, salt sensitivity and high blood pressure
11. Biomatrica Launches New Partnership Program - Biomatrica Connect(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
PAL-MED CONNECT partners with Briefings in Palliative, Hospice, and Pain Medicine & Management
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance ... consulting, provides a free webinar on Performing Quality Investigations: Getting to ... 12pm CT at no charge. , Incomplete investigations are still a major concern ...
Breaking Biology Technology: